Tag: Ppa

In the year 2000, the U.S. Food and Drug Administration (FDA) issued a public health advisory concerning the popular decongestant ingredient phenylpropanolamine (PPA), which led to the banning of many over-the-counter products, including certain formulations of Drixoral. This decision was based on new scientific evidence linking PPA to an increased risk of hemorrhagic stroke, a severe and potentially life-threatening side effect.

In 2000, Bayer removed Phenylpropanolamine (PPA) from its Alka-Seltzer Plus formulations following an FDA advisory [1.2.8, 1.2.2]. This article answers: What ingredient was removed from Alka-Seltzer and why was this once-common decongestant taken off the market?

Between 200 and 500 strokes per year among users aged 18 to 49 were estimated to be caused by products containing phenylpropanolamine (norephedrine), leading to its withdrawal from the market around 2000. This substance, also known as PPA, had a complex history of use, but its association with severe health risks has since redefined what is norephedrine used for in modern medicine.

In 1986, Contac, a popular cold medication, was pulled from store shelves following a product tampering scare. But this was not the only safety issue to change the product; the far more permanent answer to **what happened to Contac medicine** lies in a later FDA ban on a key ingredient.

In November 2000, the FDA issued a public health warning and requested that drug companies discontinue marketing products containing phenylpropanolamine (PPA), a key ingredient in Naldecon [1.6.2, 1.6.7]. So, the answer to 'Is Naldecon still available?' is no, not in its original formulation.

In November 2000, the U.S. Food and Drug Administration (FDA) issued a public health advisory recommending against the use of products containing phenylpropanolamine (PPA) due to an increased risk of hemorrhagic stroke. This included medications whose active ingredient was the same as the veterinary drug Propalin, meaning Propalin is definitively not for humans.

Following a 2000 U.S. Food and Drug Administration (FDA) public health advisory, the drug formerly known by the misspelling **propanolamine**, correctly identified as phenylpropanolamine, was withdrawn for human consumption due to the increased risk of hemorrhagic stroke. Today, while no longer available for human use in many countries, it continues to be prescribed in veterinary medicine for certain conditions.